This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Beckman Research Institute, City of Hope. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- La Canada Flintridge, CA (US) (2023)
- Pasadena, CA (US) (2023)
Company Filing History:
Years Active: 2023
Title: Cy Aaron Stein: Innovator in Cancer Treatment
Introduction
Cy Aaron Stein is a notable inventor based in Pasadena, CA, who has made significant contributions to the field of cancer treatment through his innovative methods and compositions. With a total of 2 patents, Stein's work focuses on enhancing the delivery of therapeutic agents to cancer cells, thereby improving treatment outcomes.
Latest Patents
Stein's latest patents include "TKI permeability enhancers," which provide methods for delivering nucleic acids and kinase inhibitors to cells. These methods are particularly useful for treating cancer by enabling the effective delivery of therapeutic nucleic acids to cancer cells. Another significant patent is "Methods for intracellular delivery and enhanced gene targeting," which discloses methods and compositions aimed at enhancing gene targeting. This method involves co-administrating a targeting molecule along with various enhancers to improve the function of the targeting molecule upon delivery to the cell.
Career Highlights
Cy Aaron Stein is currently associated with City of Hope, a leading research and treatment center for cancer. His work at this institution has allowed him to focus on developing innovative solutions that address critical challenges in cancer therapy.
Collaborations
Stein collaborates with esteemed colleagues such as Daniela Castanotto and Xiaowei Zhang, contributing to a dynamic research environment that fosters innovation and discovery in cancer treatment.
Conclusion
Cy Aaron Stein's contributions to cancer treatment through his patents and collaborative efforts highlight his role as a key innovator in the field. His work continues to pave the way for advancements in therapeutic delivery methods, ultimately benefiting patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
